Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice

The authors have brought to the publisher's attention that there were some errors in Fig. 1 of the article and Table 1 of the Supplementary Material published in the above article in Thrombosis and Haemostasis , Volume 118, Number 8, 2018 (DOI: 1 10.1055/s-0038-1673689 ). The corrected figure and table appear as follows:

Fig. 1.

Selection of patients receiving apixaban or warfarin as outpatient therapy for VTE. IVCF, inferior vena cava filter; OAC, oral anticoagulant; PAC, parenteral anticoagulant; VTE, venous thromboembolism.